Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression

NCT: NCT07423273 · RECRUITING

NCT IDNCT07423273
StatusRECRUITING
Start Date2023-11-08
Completion2030-12-01

Brief Summary

The study evaluates the effect of HBOT on depression in patients suffering from persistent symptoms of post stroke depression (PSD) in an double blind sham control study.

Frequently Asked Questions

What is Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression?

Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression is a clinical trial registered under NCT07423273. Current status: RECRUITING.

What is the status of NCT07423273?

The current status of NCT07423273 (Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression) is: RECRUITING.

When did Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression start?

Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression started on 2023-11-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑